Novocure Ltd at JPMorgan Healthcare Conference Transcript
Good morning, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan, and we're continuing the 42nd Annual Healthcare Conference today with Novocure. I'm joined by the company's Executive Chairman, Bill Doyle. He's going to give a presentation on the business, and then we're going to move into Q&A. If you're in the room and you want to ask a question, you can raise your hand, someone will bring you a microphone or you can always submit questions to me on the portal.
So with that, let me turn it over to Bill.
Thanks, Jess. Thanks, JPMorgan, and welcome, everyone, to day 3, first thing in the morning. I'd like to introduce Ashley Cordova. Many of you know Ashley. But she's our CFO and she'll be joining me for the Q&A today.
I hear a little bit of feedback. Are we okay? Okay. Great.
So first off, I'll be making forward-looking statements. You can find our full disclosure on the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
